Using live CBAs expressing conformational MOG it was subsequently demonstrated that a minority of patients with AQP4-IgG seronegative NMOSD were MOG-IgG positive, expanding the clinical phenotype of this antibody beyond ADEM to include optic neuritis and myelitis (55–57). This evidence concerns the gene MOG and myelitis.